本文综述了比索洛尔药效学,药代动力学和临床研究等,可以看出该药药理作用较强,付反应小,对心脏β_1受体有高度选择性,无内在拟交感活性,对高血压和心绞痛有肯定疗效,是一种有希望的新型β受体阻滞剂。 This review summarizes the pharmacodynamics, pharmacokinetics and clinical studies of bisoprolol. It can be seen that the drug has a strong pharmacological action and a small response, has a high degree of selectivity for cardiac β 1 receptor, and has no intrinsic sympathomimetic activity. Hypertension and angina have a positive effect, is a promising new β-blocker.